The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

President Donald Trump’s administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer ...

Hims & Hers' scalable model, product launches, and global expansion plans support its ambitious 2030 revenue and EBITDA ...

Hims & Hers Health, Inc. is a Strong Buy with rapid revenue growth, solid fundamentals, and 26% projected upside. Click for ...

Hims & Hers announces plans to expand its weight loss program to Canada in 2026. Novo Nordisk is set to lose patent protection on Ozempic and Wegovy in Canada next year. Post-Labor Day Trading Could ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions itself as a consumer-first health and ...

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc. (NYSE:HIMS) announced expanding into Canada with a new affordable ...

ZAVA served 1.3 million+ customers and delivered 2.3 million consultations across four European countries in 2024. Needham sees $52.1 billion in weight loss market potential in ZAVA’s existing regions ...

We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the biggest performers on Wednesday. Hims & Hers rallied for a second day on ...